Becton, Dickinson and Company BDX
- Market cap
- $48.8B
- P/E
- 55.4×
Follow BDX
Becton, Dickinson and Company (BDX) Return on invested capital
Becton, Dickinson and Company's return on invested capital over the twelve months to 30 June 2026 was 3.89%, up 0.1 percentage points from fiscal 2025 (3.82%). Over the past ten years it has ranged from 1.50% (fiscal 2020) to 5.49% (fiscal 2016); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 3.82% | 0.21 |
| FY2024 | 3.61% | 0.23 |
| FY2023 | 3.38% | (0.37) |
| FY2022 | 3.75% | 0.08 |
| FY2021 | 3.67% | 2.17 |
| FY2020 | 1.50% | (1.35) |
| FY2019 | 2.85% | 0.41 |
| FY2018 | 2.44% | (3.02) |
| FY2017 | 5.46% | (0.03) |
| FY2016 | 5.49% | 1.54 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| RMD ResMed Inc. compare | 21.4% |
| MDLN Medline Inc. compare | 19.9% |
| ISRG Intuitive Surgical, Inc. compare | 16.5% |
| WST West Pharmaceutical Services, Inc. compare | 15.4% |
| SOLV Solventum Corporation compare | 13.4% |
| BDX Becton, Dickinson and Company | 3.89% |
| ALC Alcon compare | 2.38% |
| RGEN Repligen Corporation compare | 2.18% |
| BAX Baxter International Inc. compare | −1.27% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on BDX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement